IN 2019, one Catalist-listed company was on the cusp of pivoting into a burgeoning industry – medical technology (medtech).

A new management team had been handed the reins of OEL Holdings, then an offshore shipyard business, with the intention of entering the medtech sector to provide medical consumables and equipment to healthcare institutions.

Then, Covid-19 brought its plans to a standstill.